357 related articles for article (PubMed ID: 35785179)
1. Construction of a Novel Prognostic Model in Lung Adenocarcinoma Based on 7-Methylguanosine-Related Gene Signatures.
Lu F; Gao J; Hou Y; Cao K; Xia Y; Chen Z; Yu H; Chang L; Li W
Front Oncol; 2022; 12():876360. PubMed ID: 35785179
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment related novel signature predict lung adenocarcinoma survival.
Chen J; Zhou R
PeerJ; 2021; 9():e10628. PubMed ID: 33520448
[TBL] [Abstract][Full Text] [Related]
3. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
4. Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma.
Li Y; Shen R; Wang A; Zhao J; Zhou J; Zhang W; Zhang R; Zhu J; Liu Z; Huang JA
Front Cell Dev Biol; 2021; 9():648806. PubMed ID: 33869203
[TBL] [Abstract][Full Text] [Related]
5. m7G-Associated subtypes, tumor microenvironment, and validation of prognostic signature in lung adenocarcinoma.
Wang G; Zhao M; Li J; Li G; Zheng F; Xu G; Hong X
Front Genet; 2022; 13():954840. PubMed ID: 36046251
[No Abstract] [Full Text] [Related]
6. A Prognostic Risk Score Based on Hypoxia-, Immunity-, and Epithelialto-Mesenchymal Transition-Related Genes for the Prognosis and Immunotherapy Response of Lung Adenocarcinoma.
Ouyang W; Jiang Y; Bu S; Tang T; Huang L; Chen M; Tan Y; Ou Q; Mao L; Mai Y; Yao H; Yu Y; Lin X
Front Cell Dev Biol; 2021; 9():758777. PubMed ID: 35141229
[No Abstract] [Full Text] [Related]
7. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma.
Jia H; Tang WJ; Sun L; Wan C; Zhou Y; Shen WZ
Front Genet; 2022; 13():1017866. PubMed ID: 36699466
[No Abstract] [Full Text] [Related]
8. Identification of a novel prognostic signature based on vitamin metabolism clustering-related genes in lung adenocarcinoma.
Chen Y; Jiang Y; Li X; Huang H; Zhou Y; Zhang C; Wang S; Bohnenberger H; Gao Y
Transl Lung Cancer Res; 2024 May; 13(5):1084-1100. PubMed ID: 38854940
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis identifies DNA damage repair-related gene HCLS1 associated with good prognosis in lung adenocarcinoma.
Liu T; Hu A; Chen H; Li Y; Wang Y; Guo Y; Liu T; Zhou J; Li D; Chen Q
Transl Cancer Res; 2023 Oct; 12(10):2613-2628. PubMed ID: 37969376
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Analysis of Immune Implication and Prognostic Value of
Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
Front Oncol; 2021; 11():798425. PubMed ID: 35047409
[TBL] [Abstract][Full Text] [Related]
11. Five glycosylation-related gene signatures predict the prognostic risks of lung adenocarcinoma.
Liu XH; Yang YM; Zhang MM; Fu HY
Gen Physiol Biophys; 2023 Nov; 42(6):479-493. PubMed ID: 37994425
[TBL] [Abstract][Full Text] [Related]
12. Chromatin Separation Regulators Predict the Prognosis and Immune Microenvironment Estimation in Lung Adenocarcinoma.
Li Z; Ma Z; Xue H; Shen R; Qin K; Zhang Y; Zheng X; Zhang G
Front Genet; 2022; 13():917150. PubMed ID: 35873497
[No Abstract] [Full Text] [Related]
13. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma.
Li N; Li Y; Zheng P; Zhan X
Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015
[TBL] [Abstract][Full Text] [Related]
14. Identification and validation of a 4-extracellular matrix gene signature associated with prognosis and immune infiltration in lung adenocarcinoma.
Chai Y; Ma Y; Feng W; Xiang H; Lu H; Jin L
Heliyon; 2024 Jan; 10(2):e24162. PubMed ID: 38293522
[TBL] [Abstract][Full Text] [Related]
15. Identification of m7G-Related miRNA Signatures Associated with Prognosis, Oxidative Stress, and Immune Landscape in Lung Adenocarcinoma.
Jiang S; Xiao M; Shi Y; Wang Y; Xu Z; Wang K
Biomedicines; 2023 May; 11(6):. PubMed ID: 37371664
[TBL] [Abstract][Full Text] [Related]
16. Development and clinical validation of a necroptosis-related gene signature for prediction of prognosis and tumor immunity in lung adenocarcinoma.
Lei K; Tan B; Liang R; Lyu Y; Wang K; Wang W; Wang K; Hu X; Wu D; Lin H; Wang M
Am J Cancer Res; 2022; 12(11):5160-5182. PubMed ID: 36504901
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of a DNA damage repair-related gene-based prediction model for the prognosis of lung adenocarcinoma.
Qin C; Fan X; Sai X; Yin B; Zhou S; Addeo A; Bian T; Yu H
J Thorac Dis; 2023 Dec; 15(12):6928-6945. PubMed ID: 38249902
[TBL] [Abstract][Full Text] [Related]
18. A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma.
Niu W; Jiang L
Math Biosci Eng; 2021 Jul; 18(5):6136-6154. PubMed ID: 34517527
[TBL] [Abstract][Full Text] [Related]
19. Prognostic roles of a novel basement membranes-related gene signature in lung adenocarcinoma.
Zhu X; Liu X; Qiu X; Niu Z; Dong W; Song Y
Front Genet; 2023; 14():1100560. PubMed ID: 36845403
[No Abstract] [Full Text] [Related]
20. Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma.
Xu ZY; Zhao M; Chen W; Li K; Qin F; Xiang WW; Sun Y; Wei J; Yuan LQ; Li SK; Lin SH
PeerJ; 2020; 8():e9530. PubMed ID: 32775050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
